Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.
“Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine. We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the Delta variant and the substantial threat it poses to children,” said Pfizer CEO Albert Bourla.
For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- Bannon: Audits Will Happen in Georgia
- Is the Pope Dying? 2022 Conclave?
- Some French Don’t Surrender! French Mayors Rebel, Will Not Enforce Vaccine Passport at Cafes
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- Stolen Motorcycle Crashes at 130mph On Live TV
- Affirmative action on Trial: Supreme Court to consider use of race in college admissions
- Vaccine Expert Warns: “We Made a Big Mistake”
- Rumors Persist Among Vatican Insiders That Pope Is Seriously Ill
- Oh Nooooo. Rock legend Meatloaf dead at 74